Alpha DNA Investment Management’s iShares MSCI USA Value Factor ETF VLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-908
Closed -$93K 639
2021
Q1
$93K Buy
908
+122
+16% +$11.8K 0.11% 123
2020
Q4
$68K Buy
+786
New +$64K 0.07% 147

Other funds holding VLUE

Alpha DNA Investment Management's VLUE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares MSCI USA Value Factor ETF (VLUE) in Q2 2021, closing a stake of 908 shares — an estimated $93K sold.

Alpha DNA Investment Management first reported a position in VLUE in Q4 2020 and held it in 2 quarters. The position peaked at $93K in Q1 2021. 470 funds tracked by Wall St. Rank hold VLUE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining iShares MSCI USA Value Factor ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 908 iShares MSCI USA Value Factor ETF shares in Q2 2021, an estimated $93K.
  • Alpha DNA Investment Management first reported a position in iShares MSCI USA Value Factor ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's iShares MSCI USA Value Factor ETF position peaked at $93K in Q1 2021.
  • 470 funds tracked by Wall St. Rank held iShares MSCI USA Value Factor ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.